Business Context and Reporting Period
This Form 8-K Current Report was filed by ImmunityBio, Inc. on June 4, 2021. The filing serves as a Regulation FD disclosure to announce an upcoming presentation at the Jefferies Virtual Healthcare Conference scheduled for 8:30 a.m. PT on the same date.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate event rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed in this specific filing. The document solely announces the timing and availability of a management presentation.
Guidance, Outlook, and Management Commentary
- Event: Dr. Patrick Soon-Shiong, Founder and Executive Chairman, will deliver a presentation at the Jefferies Virtual Healthcare Conference.
- Availability: Senior management will be available for discussion following the presentation.
- Access: A replay of the webcast and the slide presentation (Exhibit 99.1) will be available via the Company's Investor Relations website.
- Legal Status: The information furnished in this report and the attached presentation is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the content of the slide presentation attached as Exhibit 99.1 for specific business updates.
- Confirm the availability of the webcast replay on the ImmunityBio Investor Relations website.
- Note that this filing does not contain audited financial data; refer to the most recent 10-K or 10-Q for financial metrics.